Modulation of HIV-enhancer activity by heterologous agents: a minireview.
The enhancer region of the human immunodeficiency virus (HIV) long terminal repeat (LTR) contains two 10-bp (5'-GGGACTTTCC) repeats (core enhancers) which constitute the binding sites for the ubiquitous inducible cellular transcription factor, NF-kappa B. The NF-kappa B motifs of the LTR play a central role in transcriptional activation of the LTR by several heterologous viral proteins and various external chemical and physical stimuli. Activation of the HIV enhancer by these agents may lead to the onset of HIV gene expression resulting in active viral replication. Viral genes and chemical agents, which interfere with the activity of the enhancers may be useful in inhibiting HIV gene expression, thereby suppressing HIV replication.
Chinnadurai
G
G
Institute for Molecular Virology, St. Louis University Medical Center, MO 63110.
D001483:Base Sequence; D015967:Gene Expression Regulation, Viral; D006678:HIV / Q000235:genetics* / Q000502:physiology; D016322:HIV Enhancer / Q000502:physiology*; D016325:HIV Long Terminal Repeat / Q000235:genetics / Q000502:physiology; D008969:Molecular Sequence Data; D016328:NF-kappa B / Q000502:physiology; D014158:Transcription, Genetic; D015533:Transcriptional Activation / Q000502:physiology*; D014779:Virus Replication
D016328:NF-kappa B